| A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars (NCT01976260) | Northwestern University | 2013-10-01 |
| A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer (NCT01911273) | Pfizer | 2013-10-01 |
| Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) (NCT01933334) | Genentech, Inc. | 2013-10-01 |
| FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer (NCT02226380) | Peking Union Medical College Hospital | 2013-10-01 |
| GSK1120212+GSK2141795 for Cervical Cancer (NCT01958112) | Dana-Farber Cancer Institute | 2013-10-01 |
| An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia (NCT01939548) | Pfizer | 2013-10-01 |
| Nitric Oxide to Treat Pulmonary Embolism (NCT01939301) | Indiana University | 2013-10-01 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation (NCT01989234) | SK Life Science, Inc. | 2013-10-01 |
| A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain (NCT02003118) | Akron Molecules AG | 2013-10-01 |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer (NCT01938573) | University of Washington | 2013-10-01 |
| Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) (NCT01893372) | M.D. Anderson Cancer Center | 2013-10-01 |
| Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) (NCT01884571) | Emory University | 2013-10-01 |
| A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (NCT01987986) | Endo USA Inc., a Keenova Therapeutics Company | 2013-10-01 |
| An Open-label Extension Study of PSMA ADC 2301 in mCRPC (NCT02020135) | Progenics Pharmaceuticals, Inc. | 2013-10-01 |
| Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy (NCT01947569) | DiaVacs, Inc. | 2013-10-01 |
| Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT02248402) | Chonnam National University Hospital | 2013-10-01 |
| Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC (NCT01945021) | Pfizer | 2013-09-30 |
| Beta 3 Agonist Treatment in Heart Failure (NCT01876433) | Henning Bundgaard | 2013-09-30 |
| A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) (NCT01871805) | Hoffmann-La Roche | 2013-09-30 |
| Japanese BAY88-8223 Monotherapy Phase II Study (NCT01929655) | Bayer | 2013-09-30 |
| Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam (NCT01953510) | Murdoch Childrens Research Institute | 2013-09-30 |
| Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer (NCT01891357) | Women's Cancer Study Group GmbH | 2013-09-30 |
| Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations (NCT01953926) | Puma Biotechnology, Inc. | 2013-09-30 |
| Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer (NCT01936363) | EMD Serono | 2013-09-30 |
| Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) (NCT01915602) | Bayer | 2013-09-27 |
| Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves (NCT01939366) | Tris Pharma, Inc. | 2013-09-27 |
| An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD (NCT01985126) | Janssen Research & Development, LLC | 2013-09-27 |
| Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) (NCT01881230) | Celgene | 2013-09-26 |
| Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (NCT01925209) | Novartis Pharmaceuticals | 2013-09-26 |
| Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel (NCT01687218) | CONRAD | 2013-09-25 |
| Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older (NCT01949090) | GlaxoSmithKline | 2013-09-25 |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers (NCT01935336) | University of Colorado, Denver | 2013-09-24 |
| Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E (NCT01931358) | U.S. Army Medical Research and Development Command | 2013-09-24 |
| Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma (NCT01879085) | Melissa Burgess, MD | 2013-09-24 |
| First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. (NCT01964287) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-09-24 |
| Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer (NCT01959490) | Case Comprehensive Cancer Center | 2013-09-24 |
| Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors (NCT01841736) | National Cancer Institute (NCI) | 2013-09-20 |
| A Feasibility Study of Prophylactic White Blood Cell Transfusions (NCT01932710) | M.D. Anderson Cancer Center | 2013-09-20 |
| A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers (NCT01943864) | GlaxoSmithKline | 2013-09-19 |
| Nintedanib (BIBF 1120) in Mesothelioma (NCT01907100) | Boehringer Ingelheim | 2013-09-19 |
| Challenge Study of an ETEC Vaccine (NCT01922856) | U.S. Army Medical Research and Development Command | 2013-09-19 |
| Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma (NCT01956695) | Institut Curie | 2013-09-18 |
| ATOM_local Ablative Therapy (NCT01941654) | Chinese University of Hong Kong | 2013-09-18 |
| NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma (NCT01894061) | Case Comprehensive Cancer Center | 2013-09-18 |
| ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis- (NCT01964196) | Astellas Pharma Inc | 2013-09-17 |
| Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome (NCT03300453) | UniQure Biopharma B.V. | 2013-09-17 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease (NCT02218099) | Astellas Pharma Europe B.V. | 2013-09-16 |
| Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC) (NCT01915589) | Bayer | 2013-09-16 |
| Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. (NCT01791101) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2013-09-16 |
| Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease (NCT02274415) | Assistance Publique - Hôpitaux de Paris | 2013-09-16 |
| Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma (NCT02025881) | Gustave Roussy, Cancer Campus, Grand Paris | 2013-09-14 |
| Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B (NCT01943799) | Gilead Sciences | 2013-09-13 |
| Probiotic (Visbiome) for Gulf War Illness (NCT03078530) | Ashok Tuteja | 2013-09-13 |
| Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans (NCT01898013) | Durham VA Medical Center | 2013-09-13 |
| Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma (NCT01961115) | Fred Hutchinson Cancer Center | 2013-09-13 |
| Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01900002) | M.D. Anderson Cancer Center | 2013-09-13 |
| Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia (NCT01876953) | City of Hope Medical Center | 2013-09-13 |
| Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer (NCT01942837) | Dana-Farber Cancer Institute | 2013-09-13 |
| Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia (NCT01937013) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-09-12 |
| A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B (NCT02065011) | Sanofi | 2013-09-12 |
| Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (NCT01913535) | Massachusetts General Hospital | 2013-09-12 |
| A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living. (NCT02094053) | Eisai Co., Ltd. | 2013-09-12 |
| A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT01951157) | PharmaMar | 2013-09-11 |
| CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01881867) | Fred Hutchinson Cancer Center | 2013-09-10 |
| Trametinib With GSK2141795 in BRAF Wild-type Melanoma (NCT01941927) | Adil Daud | 2013-09-10 |
| An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT01867762) | Janssen Research & Development, LLC | 2013-09-09 |
| Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies (NCT01947140) | Jennifer Amengual | 2013-09-09 |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer (NCT01959672) | University of Nebraska | 2013-09-06 |
| Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT (NCT01892267) | Johns Hopkins University | 2013-09-06 |
| A Safety and Efficacy Study of Eltrombopag in Subjects With AML (NCT01890746) | Novartis Pharmaceuticals | 2013-09-05 |
| Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer (NCT01932697) | Mayo Clinic | 2013-09-04 |
| Tivozanib + Enzalutamide in Adv Prostate Cancer (NCT01885949) | Massachusetts General Hospital | 2013-09-03 |
| NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer (NCT01816594) | Novartis Pharmaceuticals | 2013-09-03 |
| Discontinuing NSAIDs in Veterans With Knee Osteoarthritis (NCT01799213) | VA Office of Research and Development | 2013-09-02 |
| Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery (NCT02225353) | Grünenthal GmbH | 2013-09-02 |
| A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) (NCT01793441) | Hoffmann-La Roche | 2013-09-01 |
| BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) (NCT01903265) | Tonix Pharmaceuticals, Inc. | 2013-09-01 |
| A Study of ENMD-2076 in Ovarian Clear Cell Cancers (NCT01914510) | University Health Network, Toronto | 2013-09-01 |
| A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer (NCT01981122) | Dendreon | 2013-09-01 |
| Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy (NCT02088502) | Isfahan University of Medical Sciences | 2013-09-01 |
| Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia (NCT01807598) | Jason Robert Gotlib | 2013-09-01 |
| A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV (NCT01949168) | St Vincent's Hospital Melbourne | 2013-09-01 |
| Acthar in Treatment of Refractory Dermatomyositis and Polymyositis (NCT01906372) | Rohit Aggarwal, MD | 2013-09-01 |
| Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy (NCT01942590) | Dwight Koeberl, M.D., Ph.D. | 2013-09-01 |
| Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo (NCT02046980) | Keimyung University Dongsan Medical Center | 2013-09-01 |
| The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma (NCT01942993) | Philip Friedlander | 2013-09-01 |
| Lorcaserin for Preventing Weight Gain Among Smokers (NCT02393547) | Mayo Clinic | 2013-09-01 |
| The Influence of Head and Neck Position About Oropharyngeal Leak Pressure and Sealing Between the Laryngeal Mask and Vocal Cord Using Different Types of Supraglottic Airway Device (NCT01960673) | National Taiwan University Hospital | 2013-09-01 |
| Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer (NCT01969955) | Chinese Academy of Medical Sciences | 2013-09-01 |
| Peri-Implantitis Surgical Treatment an RCT Study (NCT02575274) | Mr. Sergio Diniz Ferreira | 2013-09-01 |
| H7N9 Mix and Match With MF59 in Healthy Adults (NCT01938742) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| Adipose Derived Regenerative Cellular Therapy of Chronic Wounds (NCT02092870) | Tower Outpatient Surgical Center | 2013-09-01 |
| BRCA1/2 and Effect of Mifepristone on the Breast (NCT01898312) | Karolinska Institutet | 2013-09-01 |
| (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma (NCT01936974) | Western Regional Medical Center | 2013-09-01 |
| Trial of the Treatment of Chronic Laryngitis With Amitryptiline (NCT02434523) | Boston Medical Center | 2013-09-01 |
| Sildenafil Impact on Ventricular Function in Patients With Heart Failure (NCT01936350) | Hospital Ana Nery | 2013-09-01 |
| Calcium Electroporation for Treatment of Cutaneous Metastases (NCT01941901) | Herlev Hospital | 2013-09-01 |
| Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer (NCT01912963) | Dana-Farber Cancer Institute | 2013-09-01 |
| [18F]Fluciclatide PET Imaging of Pazopanib Response (NCT01961583) | Asan Medical Center | 2013-09-01 |
| A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease (NCT01907087) | BioMarin Pharmaceutical | 2013-09-01 |